The joint 30th Annual Meeting of the Australian Neuroscience Society and the 50th Anniversary Meeting of the Australian Physiological Society, held in Sydney, included topics covering new developments in the fields of neuroscience and physiology. This conference report highlights selected presentations on potential treatments for neuropathic pain, mood disorders and Alzheimer's disease. Investigational drugs discussed include 4-ACPBPA (Circadian Technologies Ltd/University of Sydney) and F-15599 (Pierre Fabre SA).
|Number of pages||3|
|Publication status||Published - Apr 2010|